RecruitingNCT04474301

Well-Being and Health-Related Quality of Life in Melanoma Patients During COVID-19 Pandemic

Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic


Sponsor

M.D. Anderson Cancer Center

Enrollment

1,152 participants

Start Date

Jun 11, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The primary purpose of this study is to gain an understanding of how experiences during the COVID-19 pandemic, regardless of COVID-19 status, may have impacted multiple domains of health-related quality of life and other areas such as COVID-19 specific psychological distress, and disruptions to health care, finances and social interactions. We will also evaluate the extent to which resiliency factors such as social support, perceived benefits under times of stress, and ability to manage stress may buffer associations between COVID-19 experiences and HRQoL. To meet these objectives, we have developed a 10-minute questionnaire that taps into these areas and is based on prior work addressing concerns of other pandemics or national crises. Participants will have previously consented to protocol PA15-0336 and have provided prior lifestyle data. This will allow us to connect the COVID-19 survey data with prior existing data.


Eligibility

Inclusion Criteria3

  • Patients who have signed consent for PA15-0336
  • Has an active email address and can be contacted via MyChart
  • Documentation of being alive per the cancer registry

Interventions

OTHERSurvey Administration

Complete survey


Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04474301


Related Trials